Neurocrine Biosciences (NBIX) Tax Rate (2019 - 2026)
Neurocrine Biosciences (NBIX) posted Tax Rate of 19.81% for Q1 2026, down 44.65% on a QoQ basis from 35.8% in Q4 2025, and down 2644.0% year-over-year from 0.78% in Q1 2025.
Neurocrine Biosciences (NBIX) Tax Rate (2019 - 2026) Analysis & Trends
Neurocrine Biosciences' Tax Rate history runs 8 years deep, the most recent figure standing at 19.81% for Q1 2026.
- Quarterly Tax Rate fell 2644.0% year-over-year to 19.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28.68% (down 572.0% YoY) and the FY2025 annual result came in at 32.15%, up 238.0% from the prior year.
- Tax Rate was 19.81% for Q1 2026 at Neurocrine Biosciences, down from 35.8% in the prior quarter.
- Across five years, Tax Rate topped out at 46.26% in Q1 2025 and bottomed at 25.8% in Q1 2024.
- A 5-year average of 26.9% and a median of 28.2% in 2025 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2024 — Tax Rate slumped 5164 bps — and 2025, when it soared 7206 bps.
- Neurocrine Biosciences' Tax Rate stood at 24.51% in 2022, then increased by 4 bps to 25.48% in 2023, then jumped by 44 bps to 36.59% in 2024, then fell by 2 bps to 35.8% in 2025, then tumbled by 45 bps to 19.81% in 2026.
- Business Quant data shows NBIX's Tax Rate at 19.81% in Q1 2026, 35.8% in Q4 2025, and 28.2% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 15.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.71% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -23.33% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 13.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 171.33% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 19.81% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 34.48% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -435.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.81% |
| Mar 31, 2026 | 19.81% |
| Mar 31, 2026 | 19.81% |
| Dec 31, 2025 | 35.80% |
| Dec 31, 2025 | 35.80% |
| Dec 31, 2025 | 35.80% |
| Sep 30, 2025 | 28.20% |
| Sep 30, 2025 | 28.20% |
| Sep 30, 2025 | 28.20% |
| Jun 30, 2025 | 32.60% |
| Jun 30, 2025 | 32.60% |
| Jun 30, 2025 | 32.60% |
| Mar 31, 2025 | 46.26% |
| Mar 31, 2025 | 46.26% |
| Mar 31, 2025 | 46.26% |
| Dec 31, 2024 | 36.59% |
| Dec 31, 2024 | 36.59% |
| Dec 31, 2024 | 36.59% |
| Sep 30, 2024 | 31.79% |
| Sep 30, 2024 | 31.79% |